AU3475693A - Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist - Google Patents

Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist

Info

Publication number: AU3475693A
Authority: AU; Australia
Prior art keywords: angiotensin; antagonist; administering; abnormal tissue; treating abnormal
Prior art date: 1992-02-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU34756/93A

Inventor

Victor Joseph Dzau

Richard Ellsworth Pratt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warner Lambert Co LLC

Original Assignee

Warner Lambert Co LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-14

Filing date

1993-01-15

Publication date

1993-09-03

1993-01-15 Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC

1993-09-03 Publication of AU3475693A publication Critical patent/AU3475693A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU34756/93A 1992-02-14 1993-01-15 Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist Abandoned AU3475693A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US83744692A	1992-02-14	1992-02-14
US837446		1992-02-14
US94259092A	1992-09-09	1992-09-09
US942590		1992-09-09

Publications (1)

Publication Number	Publication Date
AU3475693A true AU3475693A (en)	1993-09-03

Family

ID=27125938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU34756/93A Abandoned AU3475693A (en)	1992-02-14	1993-01-15	Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist

Country Status (5)

Country	Link
EP (1)	EP0625902A1 (en)
JP (1)	JPH07503729A (en)
AU (1)	AU3475693A (en)
IL (1)	IL104527A0 (en)
WO (1)	WO1993015734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3883205B2 (en) *	1994-03-29	2007-02-21	メルクエンドカンパニーインコーポレーテッド	Treatment of Atherosclerosis with Angiotensin II Receptor Blocking Imidazole
SG92610A1 (en) *	1997-10-24	2002-11-19	Univ Singapore	The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
HUE025599T2 (en) *	2007-06-07	2016-05-30	Sigma Tau Ind Farmaceuti	5beta, 14beta-androstane derivatives useful for the treatment of diseases due to organ fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4812462A (en) *	1986-04-01	1989-03-14	Warner-Lambert Company	4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
EP0498361A3 (en) *	1991-02-06	1992-09-02	Schering Corporation	Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor

1993
- 1993-01-15 AU AU34756/93A patent/AU3475693A/en not_active Abandoned
- 1993-01-15 JP JP5514070A patent/JPH07503729A/en active Pending
- 1993-01-15 WO PCT/US1993/000390 patent/WO1993015734A1/en not_active Ceased
- 1993-01-15 EP EP93903529A patent/EP0625902A1/en not_active Withdrawn
- 1993-01-27 IL IL104527A patent/IL104527A0/en unknown

Also Published As

Publication number	Publication date
IL104527A0 (en)	1993-05-13
JPH07503729A (en)	1995-04-20
WO1993015734A1 (en)	1993-08-19
EP0625902A1 (en)	1994-11-30

Similar Documents

Publication	Publication Date	Title
AU5540594A (en)	1994-05-24	Method of performing ophthalmic surgery
AU7689791A (en)	1991-11-11	Drug-free method for treatment of alopecia
AU4411297A (en)	1998-04-14	Combination therapy for treatment of psychoses
AU4582797A (en)	1998-04-02	Methods for treatment of retinal diseases
AU4612593A (en)	1994-04-14	Fibrillation induction method for implantable devices
AU1743195A (en)	1995-10-03	Method and apparatus for dual chamber cardiac pacing
AUPN271295A0 (en)	1995-05-25	Method of treatment
GB2298370B (en)	1997-07-16	Magnetic stimulator for neuro-muscular tissue
AU5960394A (en)	1994-08-15	Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
AU1463792A (en)	1992-10-06	N-substituted (alpha-imidazolyl-toluyl) pyrrole angiotensin ii antagonists for treatment of circulatory disorders
AU8534291A (en)	1992-03-02	Renal-selective angiotensin ii antagonists for treatment of hypertension
AU3730093A (en)	1993-09-13	Methods of treating diabetes
AU2685892A (en)	1993-05-03	Method of treating blood
AU3475693A (en)	1993-09-03	Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist
AU4220193A (en)	1993-11-29	Deazaaminopterins for treatment of inflammation
AU3263795A (en)	1996-03-14	Medicament for treatment or prophylaxis of incontinence
AU6294094A (en)	1994-10-11	An apparatus for medical treatment
ZA931010B (en)	1994-08-12	Method of treating abnormal tissue proliferation by administering an angiotensin II antagonist
AU5713196A (en)	1996-11-07	Method for treatment of pain
IL126158A0 (en)	1999-05-09	Method for treating substance abuse
AU7113996A (en)	1997-04-09	Methods of treating beta-amyloid-associated conditions
AU4119993A (en)	1993-11-29	Heteroaroyl-10-deazaaminopterins for treatment of inflammation
GB9317943D0 (en)	1993-10-13	Treatment of laminitis
AU7656394A (en)	1995-03-27	Method of treating an object by means of equipement having at least one treatment unit
AU663369B2 (en)	1995-10-05	Method of treating GAR-transformylase-dependent tumors